Large-scale testing (Phase 3)Study completedNCT03006770
What this trial is testing
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Who this might be right for
Critical Limb Ischemia (CLI)
Pluristem Ltd. 213